These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Familial hyperproinsulinemia due to a proposed defect in conversion of proinsulin to insulin. Gruppuso PA; Gorden P; Kahn CR; Cornblath M; Zeller WP; Schwartz R N Engl J Med; 1984 Sep; 311(10):629-34. PubMed ID: 6382002 [TBL] [Abstract][Full Text] [Related]
27. Effects of dexamethasone on glucose-induced insulin and proinsulin release in low and high insulin responders. Grill V; Pigon J; Hartling SG; Binder C; Efendic S Metabolism; 1990 Mar; 39(3):251-8. PubMed ID: 2407926 [TBL] [Abstract][Full Text] [Related]
28. Comparison of insulin and proinsulin storage in an islet adenoma and adjacent pancreas. Lindall AW; Steffes MW; Wong ET Metabolism; 1974 Mar; 23(3):249-56. PubMed ID: 4360551 [No Abstract] [Full Text] [Related]
30. Porcine and human insulin (Novo): a comparison of their metabolism and hypoglycemic activity in normal man. Adeniyi-Jones RO; Jones RH; Barnes DG; Gerlis LS; Sönksen PH Diabetes Care; 1983; 6 Suppl 1():9-12. PubMed ID: 6343043 [TBL] [Abstract][Full Text] [Related]
31. Proinsulin-like component of circulating insulin in the basal state and in patients and hamsters with islet cell tumors. Gorden P; Sherman B; Roth J J Clin Invest; 1971 Oct; 50(10):2113-22. PubMed ID: 4330005 [TBL] [Abstract][Full Text] [Related]
32. Disposition of 131I proinsulin in the rat. Comparisons with 131 I insulin. Izzo JL; Roncone AM; Helton DL; Izzo MJ Diabetes; 1978 Apr; 27(4):400-10. PubMed ID: 640245 [No Abstract] [Full Text] [Related]
33. Dose-response characteristics of human proinsulin and insulin in non-insulin-dependent diabetic humans. Davis SN; Monti L; Piatti PM; Brown M; Hetherington C; Orskov H; Sobey W; Hales CN; Alberti KG Am J Physiol; 1992 Jul; 263(1 Pt 1):E28-35. PubMed ID: 1636698 [TBL] [Abstract][Full Text] [Related]
34. Application of radioreceptor assay to circulating insulin, growth hormone, and to their tissue receptors in animals and man. Gorden P; Gavin JR; Kahn CR; Archer JA; Lesniak M; Hendricks C; Neville DM; Roth J Pharmacol Rev; 1973 Jun; 25(2):179-87. PubMed ID: 4581041 [No Abstract] [Full Text] [Related]
35. The effects of human proinsulin on glucose turnover and intermediary metabolism. Davis SN; Butler PC; Brown M; Beer S; Sobey W; Hanning I; Home PD; Hales CN; Alberti KG Metabolism; 1991 Sep; 40(9):953-61. PubMed ID: 1895960 [TBL] [Abstract][Full Text] [Related]
36. Biosynthetic human insulin and proinsulin have additive but not synergistic effects on total body glucose disposal. Revers RR; Henry R; Schmeiser L; Kolterman O; Cohen R; Rubenstein A; Frank B; Galloway J; Olefsky JM J Clin Endocrinol Metab; 1984 Jun; 58(6):1094-8. PubMed ID: 6373809 [TBL] [Abstract][Full Text] [Related]
37. The metabolic effects of biosynthetic human proinsulin in individuals with type I diabetes. Bergenstal RM; Cohen RM; Lever E; Polonsky K; Jaspan J; Blix PM; Revers R; Olefsky JM; Kolterman O; Steiner K J Clin Endocrinol Metab; 1984 Jun; 58(6):973-9. PubMed ID: 6373814 [TBL] [Abstract][Full Text] [Related]
39. Immunoradiometric assay of insulin, intact proinsulin and 32-33 split proinsulin and radioimmunoassay of insulin in diet-treated type 2 (non-insulin-dependent) diabetic subjects. Clark PM; Levy JC; Cox L; Burnett M; Turner RC; Hales CN Diabetologia; 1992 May; 35(5):469-74. PubMed ID: 1521730 [TBL] [Abstract][Full Text] [Related]
40. Substances immunologically related to proinsulin or connecting peptide in swine plasma. Stoll RW; Touber JL; Ensinck JW; Williams RH Horm Metab Res; 1970 May; 2(3):153-6. PubMed ID: 5521402 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]